anthrax infection
anthrax infection
Explore linked clinical trials. Standard reference: MONDO:000511910 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Effect of Activated Charcoal on Serum Osmolality, Osmolal Gap, and Enzymatic Ethylene Glycol Assay | Bacillaceae infectious disease, Bacterial Infections and Mycoses, Infections, anthrax infection, bacterial infectious disease, gram-positive bacterial infections | Active, not recruiting | Not stated | 2026-07-31 | NCT07220031 | |
| Combined Gastrointestinal Decontamination in Acute Severe Poisoning | Bacillaceae infectious disease, Bacterial Infections and Mycoses, Chemically-Induced Disorders, Infections, anthrax infection, bacterial infectious disease, gram-positive bacterial infections, poisoning | Recruiting | Phase 2 | 2026-07-06 | NCT07201311 | |
| Cigarette Filter Study | Bacillaceae infectious disease, Bacterial Infections and Mycoses, Infections, anthrax infection, bacterial infectious disease, gram-positive bacterial infections | Recruiting | Not applicable | 2026-06-05 | NCT07348679 | |
| SGLT2 Inhibitor Utilization Re-perfusion Therapy | Bacillaceae infectious disease, Bacterial Infections and Mycoses, Infections, anthrax infection, bacterial infectious disease, gram-positive bacterial infections | Not yet recruiting | Phase 4 | 2026-04-03 | NCT06858436 | |
| Observational Study of Raxibacumab in Sporadic Cases of Systemic Anthrax | Bacillaceae infectious disease, Bacterial Infections and Mycoses, Infections, anthrax infection, bacterial infectious disease, gram-positive bacterial infections | Not yet recruiting | Not stated | 2026-03-17 | NCT07478471 | |
| A Field Study Evaluating Clinical Benefit and Safety of AIGIV (ANTHRASIL®) in Inhalational Anthrax Patients | Bacillaceae infectious disease, Bacterial Infections and Mycoses, Infections, anthrax infection, bacterial infectious disease, gram-positive bacterial infections, inhalational anthrax | Not yet recruiting | Not stated | 2026-02-06 | NCT03569553 | |
| Observational Study Evaluating Clinical Benefit and Safety of AIGIV (ANTHRASIL®) in Patients With Systemic Anthrax | Bacillaceae infectious disease, Bacterial Infections and Mycoses, Infections, anthrax infection, bacterial infectious disease, gram-positive bacterial infections | Not yet recruiting | Not stated | 2026-02-06 | NCT03569514 | |
| Clinical Benefit and Safety of Raxibacumab in Patients With Symptomatic Inhalational Anthrax in a Mass Exposure Scenario | Bacillaceae infectious disease, Bacterial Infections and Mycoses, Infections, anthrax infection, bacterial infectious disease, gram-positive bacterial infections | Not yet recruiting | Phase 4 | 2026-02-06 | NCT02177721 | |
| Activated CHARcoal in Poisoned Patient - Pilot Trial | Bacillaceae infectious disease, Bacterial Infections and Mycoses, Chemically-Induced Disorders, Infections, anthrax infection, bacterial infectious disease, gram-positive bacterial infections, poisoning | Recruiting | Phase 4 | 2026-01-29 | NCT05471479 | |
| Evaluation of Clinical Benefit and Safety Following CYFENDUS Administration for Post-Exposure Prophylaxis of Anthrax Disease. | Bacillaceae infectious disease, Bacterial Infections and Mycoses, Infections, anthrax infection, bacterial infectious disease, cutaneous anthrax, gastrointestinal anthrax, gram-positive bacterial infections, inhalational anthrax | Not yet recruiting | Not stated | 2025-12-08 | NCT07268612 |